The enduring activity features two faculty recognized as experts in managing MM and highlights the use of anti-CD38 monoclonal antibody based quadruplet regimens in the treatment of patients with newly diagnosed multiple myeloma (NDMM). As a result of participating in this activity, learners will be better able to: 1: Identify the rationale for anti-CD38 monoclonal antibody-based quadruplet regimens in the treatment of patients with newly diagnosed multiple myeloma (NDMM); 2: Evaluate the clinical implications of evidence on anti-CD38 monoclonal antibody-containing quadruplet therapies in patients with NDMM; and, 3: Review strategies to optimize anti-CD38 monoclonal antibody-containing quadruplet therapies, including in the community setting. Learners have access to downloadable materials.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 27 Trinity Place, Suite 185
Pricing
99% of listed courses are free
156 of 157 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General Internal Medicine
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Infectious Disease
- Interventional Cardiology
- Maternal-Fetal Medicine
- Medical Oncology
- Nephrology
- Neurocritical Care
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Infectious Diseases
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Transplant Hepatology
- Urological Oncology
- Urology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pathology & Lab
- Pediatrics
- Primary care
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Microlearning
- Credit · Up to 0.5 credits
- Commercial Support
-
ReleasedDec 29, 2025
-
Last day to claim creditDec 29, 2026 3 months left
-
Medscape, LLC Case-Based Guide for CD38-Targeted Monoclonal Antibody Therapy in the Treatment of Multiple Myeloma
-
National Comprehensive Cancer Network Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma
-
Physicians’ Education Resource Module 5: Medical Crossfire in Newly Diagnosed and Relapsed Refractory Multiple Myeloma
-
Answers in CME Inc. (AiCME) Optimizing Frontline Care in NDMM: Translating Recent Advances Into Practice
-
Answers in CME Inc. (AiCME) Mastering Anti-CD38 Therapy in Multiple Myeloma Care: Case-Based Education for Oncology Nurses and Advanced Practitioners
-
Multiple Myeloma Research Foundation (MMRF) +1 Clinical Pearls for Subcutaneous Delivery: Optimizing Anti-CD38 Delivery in Multiple Myeloma
